| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.21 | 4e-06 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |